Company Hires Cardiac Industry Veteran to Lead Technology Development
SANTA CLARA, Calif., August 04, 2022--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a developmental stage digital healthcare company with a proprietary ECG telemedicine technology for heart attack detection, announced today the appointment of Ken Persen to the role of Chief Technology Officer. Persen has extensive technology, executive and start-up experience in healthcare and cardiac device industries. He will lead the overall technology strategy and development of the HeartBeam AIMI™ and HeartBeam AIMIGo™ platforms.
"I am very excited to join the HeartBeam team and lead the development of the first-of-its-kind remote 3D vector electrocardiogram technology," said Persen. "The promise of HeartBeam’s technology to substantially change the way that patients and healthcare professionals manage heart attack symptoms is even more compelling."
Persen has over 25 years of experience in the digital healthcare and cardiac device industries. Most recently, Persen founded LIVMOR, Inc. a digital health company, where he served as Chief Technology Officer. Persen began his career in the cardiac rhythm device industry in software engineering and development roles with Guidant Corporation and Cameron Health, both subsequently acquired by Boston Scientific, and then held leadership roles with medical informatics instruments and systems delivering electronic medical care, before founding LIVMOR.
"We are very pleased to welcome Ken onto our leadership team," said Branislav Vajdic, Ph.D. HeartBeam CEO and founder. "He brings a deep knowledge of innovation and technology, combined with industry insights, which will support continued development and evolution of HeartBeam’s technology."
HeartBeam, Inc. (NASDAQ: BEAT) is a development stage digital healthcare company with proprietary ECG telemedicine technology that will redefine the way high risk cardiovascular patients are diagnosed in an ambulatory setting at any time and any place. Its breakthrough solution employs a reusable, credit card sized, 3D vector ECG recording device and cloud-based software capable of assisting a physician in diagnosing a wide range of cardiovascular disease. HeartBeam is initially focusing on a huge unmet need of helping diagnose heart attacks in patients outside of a medical institution. No single lead ECG technology can offer this value to patients and their physicians. This underserved market is several times larger than the cardiac arrhythmia detection market based on the prevalence of patients with coronary artery disease at high risk of heart attack. For more information, visit www.heartbeam.com.
All statements in this release that are not based on historical fact are "forward-looking statements." While management has based any forward-looking statements included in this release on its current expectations, the information on which such expectations were based may change. Forward-looking statements involve inherent risks and uncertainties which could cause actual results to differ materially from those in the forward-looking statements, as a result of various factors including those risks and uncertainties described in the Risk Factors and in Management’s Discussion and Analysis of Financial Condition and Results of Operations sections of our in our Forms 10-K, 10-Q and other reports filed with the SEC and available at www.sec.gov. We urge you to consider those risks and uncertainties in evaluating our forward-looking statements. We caution readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Except as otherwise required by the federal securities laws, we disclaim any obligation or undertaking to publicly release any updates or revisions to any forward-looking statement contained herein (or elsewhere) to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220804005591/en/
Media and Investor Relations Contact: Chris Tyson Executive Vice President MZ North America Direct: 949-491-8235 BEAT@mzgroup.us www.mzgroup.us
(Bloomberg) -- Saudi billionaire Prince Alwaleed Bin Talal invested more than $500 million in Russian firms in the days around Moscow’s invasion of Ukraine.Most Read from BloombergAnshu Jain, Deutsche Bank Chief in a Pivotal Era, Dies at 59Ukraine Latest: First UN Wheat Cargo Sets Sail for EthiopiaHow the US Toppled the World’s Most Powerful Gold TraderUS Lawmakers Visit Taiwan After Pelosi Trip Draws China’s IreSaudi Billionaire Made $500 Million Russia Bet Near War’s OnsetPrince Alwaleed’s inv
In this article, we will be taking a look at 10 stocks that will skyrocket. To skip our detailed analysis of cheaply-valued stocks that are set to gain in the future, you can go directly to see the 5 Stocks That Will Skyrocket. With the U.S. stock market plunging into bear territory, investors have typically […]
The market is unstable. Your portfolio doesn’t need to be.
It's been a somewhat hectic August for Rivian . The startup, which is presented as one of Tesla's most serious rivals in the race for electric vehicles, is currently accumulating setbacks. The electric vehicle manufacturer has just announced mixed earnings for the second quarter.
Grantham remains ultra bearish. But this trio may offer some protection.
The Oracle of Omaha knows how to beat inflation. So ride his coattails.
In this article, we will be taking a look at 10 healthcare stocks to watch amid Senate’s healthcare bill. To skip our detailed analysis of these stocks and how they will be impacted by the new laws, you can go directly to see the 5 Healthcare Stocks to Watch Amid Senate’s Healthcare Bill. On August 7, […]
Rogers knows how to survive — and thrive — in turbulent times.
The stock market rally has run up to a test of its 200-day line. Apple, Microsoft are near buy points. Tesla rival Li Auto reports Monday.
These passive-income giants, with yields ranging from 7.4% to 11.8%, have the potential to nearly triple investors' money by the turn of the decade.
Shareholders in Rocket Lab USA, Inc. ( NASDAQ:RKLB ) may be thrilled to learn that the analysts have just delivered a...
The analysts covering Veru Inc. ( NASDAQ:VERU ) delivered a dose of negativity to shareholders today, by making a...
On Friday, five of China's biggest state firms announced their exit from Wall Street. More delistings could be on the way as Washington and Beijing remained embroiled in a dispute over audit rules for U.S.-listed Chinese companies.
Most of the handful of Wall Street analysts covering Berkshire are neutral on the stock, but they may be giving Warren Buffett insufficient credit.
Tesla has given investors something to look forward to this coming week: a three-for-one stock split. As of the close of trading on Aug. 24, Tesla shareholders will get a “dividend” of two extra shares. The next day, Tesla stock will start trading at the new price—a third of what it used to be.
The billionaire massively bought Amazon shares and strengthened his position at Alphabet in the midst of a market rout in the second quarter.
The latest analyst coverage could presage a bad day for Lucid Group, Inc. ( NASDAQ:LCID ), with the analysts making...
These innovative growth stocks are ripe for the picking following a 34% peak plunge in the Nasdaq Composite.
Readers hoping to buy Microsoft Corporation ( NASDAQ:MSFT ) for its dividend will need to make their move shortly, as...
Upstart Holdings' (NASDAQ: UPST) stock price tumbled 12% on Aug. 9 after the online lending company posted its second-quarter earnings report. Instead, it acts as an intermediary for its lending partners, which then fund the actual loans and pay Upstart fees for accessing its platform.